Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997

BACKGROUND: Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have therefore created temporary indication-specific market exclusivities to incentiviz...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahragardjoonegani, Babak, Beall, Reed F., Kesselheim, Aaron S., Hollis, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780607/
https://www.ncbi.nlm.nih.gov/pubmed/33397471
http://dx.doi.org/10.1186/s40545-020-00282-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780607/
https://www.ncbi.nlm.nih.gov/pubmed/33397471
http://dx.doi.org/10.1186/s40545-020-00282-8

Ejemplares similares